• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

DiaMedica Therapeutics Inc. - Common Stock (NQ:DMAC)

7.440 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 1, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about DiaMedica Therapeutics Inc. - Common Stock

< Previous 1 2 3 Next >
News headline image
DiaMedica (DMAC) Q4 2025 Earnings Transcript ↗
June 01, 2026
DiaMedica (DMAC) Q4 2025 Earnings Transcript 
Via The Motley Fool
Topics Intellectual Property
News headline image
DiaMedica (DMAC) Q1 2026 Earnings Transcript ↗
May 08, 2026
DiaMedica (DMAC) Q1 2026 Earnings Transcript 
Via The Motley Fool
Topics Death
DiaMedica Therapeutics (NASDAQ:DMAC) Posts Wider Q1 Loss but Clinical Catalysts Fuel Stock Resilience ↗
May 06, 2026
Via Chartmill
News headline image
Earnings Scheduled For November 12, 2025 ↗
November 12, 2025
 
Via Benzinga
News headline image
Exploring DiaMedica Therapeutics's Earnings Expectations ↗
August 11, 2025
 
Via Benzinga
News headline image
Earnings Scheduled For November 13, 2024 ↗
November 13, 2024
 
Via Benzinga
News headline image
Preview: DiaMedica Therapeutics's Earnings ↗
November 12, 2024
 
Via Benzinga
News headline image
Recap: DiaMedica Therapeutics Q4 Earnings ↗
March 19, 2024
 
Via Benzinga
News headline image
Top Wall Street Forecasters Revamp DiaMedica Therapeutics Expectations Ahead Of Q4 Earnings ↗
March 30, 2026
DiaMedica Therapeutics (NASDAQ: DMAC) will release Q4 earnings on March 30. Analysts expect a quarterly loss of 18 cents per share. Stock fell 0.9% on Friday. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
November 14, 2025
 
Via Benzinga
News headline image
DiaMedica Therapeutics Inc (NASDAQ:DMAC) Reports Q3 2025 Earnings and Clinical Progress ↗
November 12, 2025
DiaMedica reports Q3 2025 results, advancing DM199 for stroke and preeclampsia. The company has a cash runway into H2 2027 to fund clinical trials. 
Via Chartmill
News headline image
An Overview of DiaMedica Therapeutics's Earnings ↗
November 11, 2025
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
October 15, 2025
 
Via Benzinga
News headline image
Earnings Outlook For DiaMedica Therapeutics ↗
November 10, 2023
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
August 18, 2025
 
Via Benzinga
News headline image
DiaMedica Posts Narrower Loss in Q2 ↗
August 12, 2025
Via The Motley Fool
Topics Intellectual Property
News headline image
DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Reports Q2 2025 Earnings: Narrower Loss and Promising Clinical Updates Drive Stock Surge ↗
August 12, 2025
DiaMedica Therapeutics reports Q2 2025 results with a narrower-than-expected loss, positive clinical updates, and strong cash position. Stock surges 19% post-earnings. 
Via Chartmill
News headline image
Insights Ahead: DiaMedica Therapeutics's Quarterly Earnings ↗
May 12, 2025
 
Via Benzinga
News headline image
Why Ericsson Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket ↗
April 15, 2025
 
Via Benzinga
News headline image
Earnings Scheduled For August 12, 2025 ↗
August 12, 2025
 
Via Benzinga
News headline image
Earnings Scheduled For May 13, 2025 ↗
May 13, 2025
 
Via Benzinga
News headline image
Earnings Scheduled For March 17, 2025 ↗
March 17, 2025
 
Via Benzinga
News headline image
This Fastenal Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday ↗
October 07, 2024
 
Via Benzinga
News headline image
DMAC Stock Earnings: DiaMedica Therapeutics Beats EPS for Q2 2024 ↗
August 07, 2024
DMAC stock results show that DiaMedica Therapeutics beat analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
News headline image
DMAC Stock Earnings: DiaMedica Therapeutics Beats EPS for Q1 2024 ↗
May 08, 2024
DMAC stock results show that DiaMedica Therapeutics beat analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
News headline image
DMAC Stock Earnings: DiaMedica Therapeutics Meets EPS for Q4 2023 ↗
March 19, 2024
DMAC stock results show that DiaMedica Therapeutics met analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗
October 25, 2023
Pre-market stock movers are a hot topic on Wednesday and we're offering all the details that investors need to know about this morning. 
Via InvestorPlace
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For June 22, 2023 ↗
June 22, 2023
 
Via Benzinga
News headline image
Earnings Scheduled For November 13, 2023 ↗
November 13, 2023
Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr (NASDAQ:DXYN) is estimated to report earnings for its third quarter. 
Via Benzinga
News headline image
DiaMedica Raises $37.5M Via Equity Offering, Aiding Development Activities For DM199 ↗
June 21, 2023
DiaMedica Therapeutics Inc. (NASDAQ: DMAC) has entered into an agreement with accredited investors that have agreed to provide up to $37.5 million in gross proceeds through a  
Via Benzinga
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap